טוען...
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2017-11-01
|
| סדרה: | BMC Cancer |
| נושאים: | |
| גישה מקוונת: | http://link.springer.com/article/10.1186/s12885-017-3729-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|